AxoSim has entered a definitive agreement to acquire Vyant Bio's StemoniX microBrain™ platform, uniting top-tier organoid technologies to accelerate neurological drug discovery.

Serial Entrepreneurs Dale Pfost and David Weiner Bring Broad Expertise as AxoSim Expands Its Leadership in Human Organoid Technologies Designed to Make Neurological R&D Faster, More Efficient and More Successful.

AxoSim has appointed Stuart Gibb as VP of Sales and Marketing. With over 20 years of experience, Stuart will help accelerate AxoSim's commercial growth in drug discovery and development.